Adma Biologics (ADMA) Research & Development (2011 - 2026)
Adma Biologics (ADMA) recorded Research & Development of $4.49 million in Q3 2026, up 193.8% from $1.53 million a year earlier but down 25.3% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Research & Development (2011 - 2026) Analysis & Trends
On a TTM basis, Adma Biologics' Research & Development came in at $14.48 million as of Sep 30, 2026, up 283.4% year-over-year; for FY2025, it came in at $4.76 million, up 162.7% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of -4.2% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $1.81 million in FY2024 (-45.1%), $3.3 million in FY2023 (-8.7%), $3.61 million in FY2022 (-0.9%) and $3.65 million in FY2021 (-38.3%).
- Quarterly Research & Development has ranged from $391,000 in Q4 2024 to $6.01 million in Q2 2026 over the past five years.
- On a year-over-year basis, Research & Development has increased for seven consecutive quarters, with growth averaging 196.2% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 483.3% in Q2 2026, against a decline of 60.1% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.01 million (Q2 2026), $2.6 million (Q1 2026) and $1.38 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn | 4.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.49 Mn |
| Jun 30, 2026 | 6.01 Mn |
| Mar 31, 2026 | 2.60 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 826,000.00 |
| Dec 31, 2024 | 391,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Jun 30, 2024 | 560,000.00 |
| Mar 31, 2024 | 450,000.00 |
| Dec 31, 2023 | 446,000.00 |
| Sep 30, 2023 | 596,000.00 |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 855,000.00 |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 873,386.00 |
| Mar 31, 2022 | 624,111.00 |
| Dec 31, 2021 | 728,928.00 |
API Access
Adma Biologics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();